Tag Archives: ZeptoMetrix

June 2023—ZeptoMetrix introduced Protrol, a line of products designed to evaluate and monitor the performance of antigen-based assays, including lateral flow immunoassays for infectious diseases. Each lot is supplied with the protein concentration and TCID₅₀ value.

April 21, 2023—ZeptoMetrix introduced Protrol, a line of products designed to evaluate and monitor the performance of antigen-based assays, including lateral flow immunoassays for infectious diseases.

January 2023—ZeptoMetrix launched its NATtrol MS2 bacteriophage quantitative stock, intended for use as an internal process control for rt-PCR assays.

December 2022—ZeptoMetrix has released its NATtrol external run control for flu A and B, RSV B, and SARS-CoV-2, for research use only.

Oct. 19, 2022—ZeptoMetrix launched two vaginal molecular QC controls, NATtrol Vaginal Positive Control and NATtrol Vaginal Negative Control, for in vitro diagnostic use.

Oct. 13, 2022—ZeptoMetrix has released its NATtrol external run control for flu A and B, RSV B, and SARS-CoV-2, for research use only.

June 2022—ZeptoMetrix announced the release of its NATtrol SARS-CoV-2 Omicron External Run Control, for research use only, to evaluate the performance of nucleic acid tests for determining the presence of SARS-CoV-2 omicron variant RNA. The control is formulated with purified, intact organisms and is for use with a real-time PCR thermal cycler. The product is available in six 0.5-mL vials and is refrigerator stable at 2° to 8°C.